Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Sheba and Toronto General Explore Lung Transplantation Advances in a Joint Conference

Sheba and Toronto General
During the conference, held at Sheba, researchers presented innovative methods for preserving lungs outside the body, which could significantly improve the outcomes of lung transplant procedures.

Clinicians from Toronto General Hospital joined Sheba’s experts at the second scientific conference arranged by Sheba’s Lung Transplant Program to explore advanced lung preservation and sterilization techniques before transplant.

One of the most significant breakthroughs discussed was a new research demonstrating techniques to preserve lungs outside the donor’s body for up to 72 hours.  Procedures for cleaning and sterilizing lungs with ultraviolet light and using lungs from type A blood donors for recipients with type O blood were also explored.

The collaboration between Sheba and Toronto General aims to utilize the respective expertise of both organizations to advance the field of lung transplantation, and encompasses, among other joint ventures, bilateral consultations on challenging patients and an exchange of trainees.

According to Dr. Liran Levy, Medical Director of Sheba’s Lung Transplant Program, “The conference is the direct result of a cooperation that began in 2019 between Sheba and Toronto General. We will continue to work together, focusing on innovation, research, and education.” 

Sheba’s Institute of Pulmonary Medicine launched the Lung Transplant Program in December 2020, which has already resulted in over 30 lung transplants, including transplants for patients whose lungs were damaged by COVID-19. 

Looking forward, we are confident that the collaboration with Toronto General Hospital will prove to be highly beneficial to patients both within Israel and around the world.

Breakthrough Research
News Jun 05.
Breakthrough Research Provides Pancreatic Cancer Patients with New Hope
Pancreatic cancer is a significant cause of cancer-related death, standing at fourth place globally. It is also the twelfth most common cancer type worldwide, with…
Read More
Sheba Study in collaboration with other medical institutions found an effective way of treatment, a type of cure for hemophilia.
News Jun 05.
Groundbreaking Sheba Study Indicates: New Gene Therapy Offers Rapid Cure for Hemophilia 
Hemophilia is a bleeding disorder that stems from a genetic mutation or alteration in the genes that encode clotting factor proteins, which are necessary for…
Read More
Sheba and Mayo Clinic merge Data-Sharing Network
News May 18.
Sheba and Mayo Clinic Partner to Transform Patient Care Through an Innovative Data-Sharing Network
Sheba Medical Center has joined the Mayo Clinic Platform Connect, a global data-sharing network that aims to revolutionize healthcare. The groundbreaking platform provides a safe,…
Read More